(Note: This is NOT an IPO. This is a NASDAQ uplisting from the OTC Pink Marketplace.) We are a MedTech company with two innovative product lines: neurology and motion products. Since October 1, 2021, we have had two direct subsidiaries, each of which is focused on one of our complimentary product lines. (Incorporated in Nevada) […]

(Note: Specialty Building Products, Inc. withdrew its IPO plans in an SEC filing dated Feb. 8, 2023. The S-1 was filed on Jan. 3, 2022. The company had not updated its prospectus since April 2022.)  We believe we are the largest and fastest-growing distributor of branded specialty building products in the United States. Since 2010, […]

(Note:  This is a unit IPO consisting of 865,385 units. Each unit consists of one share of stock and three warrants, each to purchase one ordinary share.) We are a development-stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield […]

(Note on corporate structure: The predecessor of our principal operating company was incorporated on March 9, 1996, in Singapore under the name Finebuild Systems Pte Ltd. Pursuant to a restructuring that took effect on August 2, 2022, FBS Global Limited, an exempted company incorporated in the Cayman Islands, through its wholly owned subsidiary, Success Elite […]

(Note: C&W Acquisition Corp. withdrew its SPAC IPO plans in an SEC filing dated Jan. 27, 2023. C&W Acquisition is a blank check company created by Cushman & Wakefield to search for target companies in real estate and PropTech (property technology). The S-1 was filed in March 2021. C&W Acquisition is incorporated in the Cayman […]

(Note: This is NOT an IPO. This is a NASDAQ uplisting from the OTC Pink Market with the proposed NASDAQ symbol of “JETR” – a public offering of 2.88 million shares (2,875,000 shares) at the assumed offering price of $4.00. A 1-for-6 reverse stock split will take effect immediately after the effectiveness of this offering […]

Note: New Ruipeng Pet Group Inc. withdrew its plans for a U.S. IPO in a letter to the SEC dated June 6, 2024. The Chinese company had filed its F-1 on Jan. 23, 2023, but it had not disclosed terms. We are China’s largest one-stop pet care platform. We operate more than 1,900 pet hospitals […]

(Note: This is NOT an IPO. This is a NASDAQ uplisting from the Tel Aviv Stock Exchange, where the stock’s last reported sale price was US$20.96 on Feb. 2, 2023, according to the prospectus. Enlight’s SEC filing calls the deal an “initial public offering” but it’s not; the stock already trades in Tel Aviv. IPOScoop […]

(Note: 5 Edge Acquisition Corp. withdrew its plans for its SPAC IPO in an SEC filing dated Jan. 18, 2023. The blank check company filed its S-1 in March 2021.) We  intend to focus our search for target companies on the telecom sector.  We intend to focus our search within the TMT sector (on areas) […]

Mineralys Therapeutics is a clinical biotechnology company developing a therapy for cardiorenal disease.  We are a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor (ASI) that we are initially developing for the treatment of […]